YopM, a 41.5 kDa virulence protein of Yersinia pestis is believed to h
ave an antiinflammatory role in bubonic plague. It has been shown prev
iously that YopM binds human alpha-thrombin but not prothrombin and in
hibits thrombin-induced platelet aggregation in vitro. In the present
studies we carried out crosslinking reactions between purified YopM an
d alpha-thrombin or its blocked form FPR-alpha-thrombin in the presenc
e of various competitors to identify where on thrombin YopM binds. We
found that thrombin cleaves YopM at the C-terminus, indicating that th
is part of YopM must interact with thrombin's catalytic site. Hirudin,
a 65 amino acid natural thrombin inhibitor, prevents both the YopM de
gradation and the formation of a ca. 75 kDa crosslinking complex betwe
en YopM and alpha-thrombin. A similar effect is observed when hirugen,
a short peptide corresponding to hirudin's C-terminus (amino acids 58
-64), is used as a synthetic thrombin inhibitor. A 15 bp long specific
oligonucleotide known to block alpha-thrombin successfully competes w
ith YopM for the thrombin-binding site, whereas a control, scrambled s
equence aptamer does not. As these competitors block a fibrinogen bind
ing site (also called anion binding exosite I), our crosslinking data
indicate that YopM binds not only to the active site of alpha-thrombin
but also to the abeI.